Rani Chennamma College of Pharmacy, Belagavi.
Objective: The goal of the current study was to develop and evaluate medicated chewing gum containing caffeine. Method: The chicle gum base was prepared by heating latex from the Sapodilla monikara tree in a water bath. To create a homogeneous mixture, lecithin obtained from eggs was added and heated for 45 minutes at 60°C. Glycerol was added to lessen stickiness after talcum powder was added for structure. For stability, the prepared gum base was kept in amber glass vials. Lecithin was extracted from the egg yolk separately by dissolving it in acetone, homogenizing it for 20 minutes, and then washing it with petroleum ether and chloroform. After filtering, the white precipitate was oven-dried for 30 minutes. After softening the gum base at 60°C, mannitol, coconut oil, and caffeine powder were added. Agents for flavoring and coloring were added once the mixture had cooled below 40°C. After molding and cooling, the gum was packaged. Results: The conventional evaluation criteria were met by all chewing gum formulations containing caffeine, suggesting that their quality was satisfactory. Formulation F1 performed the best out of all of them, meeting every requirement. Its overall performance, stability and uniformity made it the best option for a medicated gum delivery system. Conclusion: Chicle gum base from Sapodilla monikara was combined with caffeine as the active ingredient. The formulation was enhanced by modified egg lecithin, and studies revealed that F1 was the best formulation.
Medicated chewing gum (MCG) is a new and increasingly investigated medication delivery platform, with several benefits over traditional oral dose forms. By avoiding first-pass metabolism and facilitating systemic drug absorption through the buccal mucosa, MCG, which is intended for mastication rather than ingestion, improves bioavailability and onset of action in addition to facilitating local therapeutic effect in the oral cavity 1. MCG has established itself as a useful dosage form in contemporary pharmaceutical research due to its user-friendly character, advantages such as simplicity of administration, quick therapeutic action, and improved patient compliance, especially among pediatric and geriatric populations. Caffeine (1,3,7-trimethylxanthine), a common central nervous system stimulant, is used to fight fatigue, improve alertness, and enhance cognitive function.There is usually a lag in the therapeutic start of traditional caffeine delivery methods, such as capsules or beverages, because of delayed gastrointestinal absorption. MCG has been suggested as a more effective distribution method to get over this restriction. Caffeine-containing chewing gum assurances quicker drug release and action by promoting buccal absorption, which is especially helpful in high-demand scenarios like emergency medicine and military operations 2. Chicle, a naturally occurring gum base made from the sap of the Manilkara zapota tree, is significant both ecologically and historically. It is a sustainable and well-liked substitute for synthetic gum bases due to its superior mechanical strength, biocompatibility, and biodegradability. Chicle's inclusion in caffeine MCG improves the chewing experience and gum matrix's structural integrity, in addition to being in line with pharmaceutical methods that are ecologically aware 3. Current studies back up MCG's viability and growing usefulness. The potential of MCG for buccal drug delivery was highlighted by Gururajbhat et al., who reported that their formulations had acceptable mechanical characteristics and drug release behavior 1. The use of MCG for the administration of bronchodilators such as terbutaline sulfate was investigated by Mishra et al., demonstrating its suitability for systemic diseases requiring rapid onset 2. The advantages of employing solid dispersion techniques to enhance solubility and release kinetics in chewing gum systems were also documented by Sharma et al. 4. The potential of vitamin C-loaded MCG as a supplemental medication that combines nutritional and dental health benefits was also shown by Pujari et al.5 The current study intends to develop and assess a medicated chewing gum with caffeine based on chicles in light of these advancements. Its physical properties, drug release behavior, and therapeutic efficacy have to be evaluated, with a focus on the use of sustainable excipients. This study adds to the increasing amount of research on efficient, environmentally friendly, and patient-friendly drug delivery methods.
MATERIALS AND METHODS
Materials: All of the reagents and substances utilized in the investigation were of analytical quality. Natural rubber latex was obtained from the medicinal garden of Rani Chennamma College of Pharmacy. Glycerin and coconut oil were procured from Mehta Sons, Bangalore, while mannitol, soy lecithin, and talc were supplied by Burgoyne Burbidges, Mumbai. Caffeine was sourced from Universal Scientific Works, Bangalore. The instruments used in this study included an electronic balance and an ultrasonicator, both supplied by The Indo Sati Instruments and Chemicals. UV absorbance readings were obtained using a UV spectrophotometer (Shimadzu-1800, Japan).
METHODS
Preparation of Standard Calibration Curve of Caffeine: Using UV spectrophotometry, a standard calibration curve for caffeine was created. In chloroform, caffeine has a maximum absorbance (λmax) at 274 nm in the 200–400 nm wavelength range. Ten milligrams of pure caffeine were precisely weighed and dissolved in one hundred milliliters of chloroform to create a stock solution with a concentration of 100 µg/mL. Standard solutions including concentrations of 2, 4, 6, 8, 10, and 12 µg/mL were made from this sample by appropriately diluting it. At 272 nm, the absorbance of every solution was measured.
Extraction of Egg Lecithin from Egg Yolk
Figure 1: Extraction of Egg Lecithin from Egg Yolk
Procedure: To extract lecithin, the egg yolk was carefully separated from the egg and dissolved in acetone. The mixture was homogenized for 20 minutes to facilitate the extraction process. The precipitate obtained was separated and subjected to a second homogenization step. The precipitate was then repeatedly washed with chloroform until a clear, white color was observed, ensuring the removal of impurities. Subsequently, it was washed with petroleum ether, followed by filtration to remove any residual solvents. To get a stable result, the purified lecithin was lastly dried for 30 minutes in a hot air oven, as in Figure 1. This method ensures the efficient extraction and purification of high-quality egg lecithin.7
Preparation of Chicle Gum Base from Sapodilla monikara
The chicle gum base was formulated using latex extracted from Sapodilla monikara, sourced from the medicinal garden of Rani Chennamma College of Pharmacy. Latex collection was performed by making a clean incision at the tip of the plant, with the exudate immediately transferred into a sterile container. The latex was then placed in a clean, dry metal vessel and gently heated in a water bath. Upon softening of the gum base, freshly extracted egg yolk lecithin (prepared in a prior step) was introduced as an emulsifying agent. The temperature was carefully maintained at 60?°C for 45 minutes to facilitate uniform dispersion of lecithin within the latex. Glycerol was incorporated into the molten mixture to reduce the inherent stickiness of the formulation and enhance its processability. Subsequently, talcum powder was added as a structural filler to improve the physical integrity of the gum. The final gum base was stored in amber-colored glass containers to protect it from light-induced degradation and preserve its stability.8
Characterization of Isolated gum base:
Figure 2: Flow chart for preparation of Caffeine-Medicated Chewing Gum
The process involved precisely weighing the gum base and then placing it in a china dish over a water bath at 60°C until it became soft. Once softened, caffeine powder (active ingredient) was incorporated, followed by coconut oil as a lubricant. The mixture was thoroughly blended to ensure uniform distribution. Subsequently, mannitol was added and mixed until a homogeneous composition was achieved. After achieving a uniform mixture, the temperature was reduced to below 40°C. Coloring and flavoring agents were gradually added while continuous mixing was maintained. The final gum mass was molded into the desired shape and set at room temperature before packaging, as in Figure 2.10
Table 1: Composition of Formulations for Caffeine-Infused Medicated Chewing Gum
Sr no |
Ingredients |
Uses |
F1 |
F2 |
F3 |
1 |
Caffeine |
API |
50mg |
50mg |
50mg |
2 |
Chicle gum base |
Base |
1000mg |
1200mg |
1400mg |
3 |
Coconut oil |
Lubricant |
2-3drop |
2-3drop |
2-3drop |
4 |
Mannitol |
Sweetening agent |
100mg |
100mg |
100mg |
5 |
Elaichi |
Flavoring agent |
Q.S |
Q.S |
Q.S |
6 |
Beetroot powder |
Coloring agent |
Q.S |
Q.S |
Q.S |
7 |
Talc |
Filler |
Q.S |
Q.S |
Q.S |
Evaluation Parameters of Caffeine-Infused Medicated Chewing Gum11-14
RESULTS:
Figure 3: Standard Calibration Curve of Caffeine:
A standard calibration curve was created using the resultant data, which plotted absorbance against concentration. According to the obtained linear regression equation, y = 0.0478x + 0.008, where y stands for absorbance and x for concentration in µg/ml, the calibration curve showed a good linear connection. The calibration curve's high linearity and reliability for the quantitative detection of caffeine in the specified solvent system were indicated by the coefficient of determination (R2), which came out to be 0.999.
Table 2: Physicochemical Characterization of Isolated Gum Base
Sr No. |
Parameters |
Observation |
1 |
Color |
Yellow |
2 |
Swelling index |
No swelling |
3 |
Solubility |
In soluble in water Soluble in dilute HCl, ethanol, and methanol |
The fundamental physicochemical characteristics of the separated gum base were assessed. Table 2 illustrates how the gum looked yellow. When exposed to water, it did not swell, suggesting that hydrophilic expansion was absent. Furthermore, the gum base's solubility profile revealed that it dissolves in ethanol, methanol, and diluted hydrochloric acid (HCl) but not in water. These properties imply that the gum might find use in situations where solubility in organic solvents and water is preferred.
Table 3: Organoleptic and Physical Evaluation of Caffeine-Infused Medicated Chewing Gum
Sr no. |
Parameter |
Observation |
||
F1 |
F2 |
F3 |
||
1 |
Color |
Pink |
Pink |
Pink |
2 |
Taste |
Sweet |
Sweet |
Sweet |
3 |
Odor |
Pleasant |
Pleasant |
Pleasant |
4 |
Stickiness |
Non-Sticky |
Non-Sticky |
Non-Sticky |
5 |
Hardness(kg/cm2) |
3.5 |
3.7 |
4 |
6 |
Average weight SD ± mg |
1000±0.05 |
1200±0.07 |
1400±0.04 |
Table 3 summarizes the physical characteristics and organoleptic characteristics of the medicated chewing gum formulations (F1, F2, and F3) that contained caffeine. Visual examination verified that all three formulations looked good, showing homogeneity in sensory qualities with a constant pink color, sweet taste, and nice odor. It was discovered that every formulation was non-sticky, which is ideal for patient compliance. The formulations' hardness values, which varied from 3.5 to 4.0 kg/cm2, showed sufficient mechanical strength for chewing. Furthermore, the formulations' average weights demonstrated adequate consistency with a low standard deviation, falling within the Indian Pharmacopoeia's (IP) suggested bounds. These findings imply that the manufactured.
Figure 4: Percentage Of Drug Content
The Drug content percentage indicates the proportion of the active pharmaceutical ingredient (API) present in each formulation, a critical parameter in evaluating the consistency and effectiveness of the drug. Among the three formulations, Furthermore, the gum base's solubility profile revealed that it dissolves in ethanol, methanol, and diluted hydrochloric acid (HCl) but not in water.
Table 4: In Vitro Drug Release Profile of Medicated Chewing Gum Infused with Caffeine
Sr no. |
Time (Min) |
Percentage Cumulative drug release |
||
F1 |
F2 |
F3 |
||
1 |
0 |
15 |
8.3 |
2.9 |
2 |
2 |
37.6 |
32.06 |
25.45 |
3 |
4 |
45.3 |
40.10 |
32.40 |
4 |
6 |
62.04 |
56.12 |
49.96 |
5 |
8 |
83 |
77.31 |
70.42 |
6 |
10 |
88.5 |
83.3 |
74.25 |
7 |
12 |
94 |
87 |
75.85 |
Figure.5: Percentage Dug Release
F1 showed the highest and fastest drug release, reaching 94% at 12 minutes, according to the in vitro release data (Table 4, Figure 5). F3 had the least amount of release (75.85%), whereas F2 had the most (87%). With F1 at 15%, F2 at 8.3%, and F3 at 2.9%, the first release at 0 minutes also varied considerably, suggesting variations in formulation qualities. According to these findings, F1 is the best option for quick drug delivery.
Stability Studies
Table 5: Short-Term Stability Study of Caffeine-Infused Medicated Chewing Gum (F1)
Time (week) |
Evolution parameters |
||||
Physical appearance |
Hardness (kg/cm2) |
Weight variation |
Uniformity of drug content (%) |
% CDR |
|
0 |
Rose pink |
3.5 |
0.05% |
48.02 |
94 |
1 |
Rose pink |
3.5 |
0.05% |
48.02 |
94 |
2 |
Rose pink |
3.5 |
0.05% |
48.02 |
94 |
3 |
Rose pink |
3.3 |
0.05% |
47.58 |
93.6 |
4 |
Rose pink |
3.1 |
0.05% |
47.25 |
93.1 |
The formulation remains physically and chemically stable over four weeks, with minor reductions in hardness, drug content, and drug release. These changes suggest that the formulation retains its quality and performance within the stability period, with no significant degradation. Further long-term stability studies may be required to assess extended shelf-life performance.
DISCUSSION
Caffeine-infused medicated chewing gum was successfully formulated and evaluated using an isolated gum base, yielding promising outcomes. The spectrophotometric analysis demonstrated excellent linearity with a regression equation of y = 0.0478x + 0.008 and a coefficient of determination (R² = 0.999), confirming the method’s accuracy and reproducibility, consistent with the findings of Anbazhagan et al.15. The isolated gum base exhibited a yellow color, no swelling in water, and solubility in ethanol, methanol, and dilute hydrochloric acid, making it suitable for oral drug delivery systems where water resistance and organic solubility are critical. These observations align with the physicochemical characteristics reported by Jani et al. 16, while Goyal and Sharma17 highlighted the relevance of such natural polymers in achieving controlled drug release. Among the formulations, F1 demonstrated superior performance, with the highest drug content (48.02%) and rapid in vitro release (94% within 12 minutes), surpassing F2 and F3. This supports the earlier work of Singh et al., who reported optimized drug release from caffeine-based chewing gum18. Stability studies conducted over four weeks indicated only minimal changes in F1’s hardness and drug content, with no notable deterioration in physical appearance or performance, which is in agreement with the findings of Patel and Rajput on the short-term stability of similar formulations19. Additionally, Yadav and Pathak20 have highlighted the benefits of medicated chewing gums, such as their capacity to avoid hepatic first-pass metabolism, enhanced bioavailability, quick onset of action, and simplicity of administration. Jadhav and Shaikh 21 further emphasized the adaptability of caffeine-infused chewing gum for pediatric use, without compromising efficacy or patient compliance.
CONCLUSION
The successful manufacture and testing of caffeine-infused medicated chewing gum, using an isolated gum base, demonstrates its potential as an effective oral drug delivery technique. F1 stood out as a good candidate for additional development among the developed formulations due to its ideal performance in terms of drug content, fast in vitro release, and short-term stability. The formulation's stability and effectiveness, along with the physicochemical characteristics of the separated gum basis, suggest its suitability for quick-acting, convenient caffeine delivery. However, more in vivo pharmacokinetic research and long-term stability evaluations are necessary to guarantee its therapeutic applicability.
REFERENCES
Vijayanand Pujari, Reshma Sawant*, Lakshmi Kurbet, Shruthi Kuligod, Vidya Dalawal, Sachin Pujari, Priyanka Khavare, A Novel Approach to Caffeine Delivery: Formulation and Evaluation of Chicle-Based Medicated Chewing Gum, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 5765-5774. https://doi.org/10.5281/zenodo.15771138